{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/08/03/3337516/29489/en/AIM-ImmunoTech-Ahead-of-Schedule-on-Last-Dose-DURIPANC-Critical-Clinical-Inflection-Point.html", "message": "News view counter 863045 successfully enlarged"}